Cargando…
Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
SIMPLE SUMMARY: Malignant melanoma is the most lethal skin cancer due to its aggressive clinical behavior and therapeutic resistance. A comprehensive knowledge of the molecular mechanisms underlying melanoma progression is urgently needed to improve the survival of melanoma patients. Phenotypic plas...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909883/ https://www.ncbi.nlm.nih.gov/pubmed/35267510 http://dx.doi.org/10.3390/cancers14051200 |
_version_ | 1784666303205736448 |
---|---|
author | Vázquez-Naharro, Alberto Bustos-Tauler, José Floristán, Alfredo Yuste, Lourdes Oltra, Sara S. Vinyals, Antònia Moreno-Bueno, Gema Fabra, Àngels Portillo, Francisco Cano, Amparo Santamaría, Patricia G. |
author_facet | Vázquez-Naharro, Alberto Bustos-Tauler, José Floristán, Alfredo Yuste, Lourdes Oltra, Sara S. Vinyals, Antònia Moreno-Bueno, Gema Fabra, Àngels Portillo, Francisco Cano, Amparo Santamaría, Patricia G. |
author_sort | Vázquez-Naharro, Alberto |
collection | PubMed |
description | SIMPLE SUMMARY: Malignant melanoma is the most lethal skin cancer due to its aggressive clinical behavior and therapeutic resistance. A comprehensive knowledge of the molecular mechanisms underlying melanoma progression is urgently needed to improve the survival of melanoma patients. Phenotypic plasticity of melanoma cells has emerged as a key process in melanomagenesis and therapy resistance. This phenotypic plasticity is sustained by an epithelial-to-mesenchymal (EMT)-like program that favors multiple intermediate states and allows adaptation to changing microenvironments along melanoma progression. Given the essential role of lysyl oxidase-like 3 (LOXL3) in human melanoma cell survival and its contribution to EMT, we generated mice with conditional melanocyte-specific targeting of Loxl3, concomitant to Braf activation and Pten deletion. Our results supported a key role of Loxl3 for melanoma progression, metastatic dissemination, and genomic stability, and supported its contribution to melanoma phenotypic plasticity by modulating the expression of several EMT transcription factors (EMT-TFs). ABSTRACT: Malignant melanoma is a highly aggressive tumor causing most skin cancer-related deaths. Understanding the fundamental mechanisms responsible for melanoma progression and therapeutic evasion is still an unmet need for melanoma patients. Progression of skin melanoma and its dissemination to local or distant organs relies on phenotypic plasticity of melanoma cells, orchestrated by EMT-TFs and microphthalmia-associated TF (MITF). Recently, melanoma phenotypic switching has been proposed to uphold context-dependent intermediate cell states benefitting malignancy. LOXL3 (lysyl oxidase-like 3) promotes EMT and has a key role in human melanoma cell survival and maintenance of genomic integrity. To further understand the role of Loxl3 in melanoma, we generated a conditional Loxl3-knockout (KO) melanoma mouse model in the context of BrafV600E-activating mutation and Pten loss. Melanocyte-Loxl3 deletion increased melanoma latency, decreased tumor growth, and reduced lymph node metastatic dissemination. Complementary in vitro and in vivo studies in mouse melanoma cells confirmed Loxl3’s contribution to melanoma progression and metastasis, in part by modulating phenotypic switching through Snail1 and Prrx1 EMT-TFs. Importantly, a novel LOXL3-SNAIL1-PRRX1 axis was identified in human melanoma, plausibly relevant to melanoma cellular plasticity. These data reinforced the value of LOXL3 as a therapeutic target in melanoma. |
format | Online Article Text |
id | pubmed-8909883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89098832022-03-11 Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival Vázquez-Naharro, Alberto Bustos-Tauler, José Floristán, Alfredo Yuste, Lourdes Oltra, Sara S. Vinyals, Antònia Moreno-Bueno, Gema Fabra, Àngels Portillo, Francisco Cano, Amparo Santamaría, Patricia G. Cancers (Basel) Article SIMPLE SUMMARY: Malignant melanoma is the most lethal skin cancer due to its aggressive clinical behavior and therapeutic resistance. A comprehensive knowledge of the molecular mechanisms underlying melanoma progression is urgently needed to improve the survival of melanoma patients. Phenotypic plasticity of melanoma cells has emerged as a key process in melanomagenesis and therapy resistance. This phenotypic plasticity is sustained by an epithelial-to-mesenchymal (EMT)-like program that favors multiple intermediate states and allows adaptation to changing microenvironments along melanoma progression. Given the essential role of lysyl oxidase-like 3 (LOXL3) in human melanoma cell survival and its contribution to EMT, we generated mice with conditional melanocyte-specific targeting of Loxl3, concomitant to Braf activation and Pten deletion. Our results supported a key role of Loxl3 for melanoma progression, metastatic dissemination, and genomic stability, and supported its contribution to melanoma phenotypic plasticity by modulating the expression of several EMT transcription factors (EMT-TFs). ABSTRACT: Malignant melanoma is a highly aggressive tumor causing most skin cancer-related deaths. Understanding the fundamental mechanisms responsible for melanoma progression and therapeutic evasion is still an unmet need for melanoma patients. Progression of skin melanoma and its dissemination to local or distant organs relies on phenotypic plasticity of melanoma cells, orchestrated by EMT-TFs and microphthalmia-associated TF (MITF). Recently, melanoma phenotypic switching has been proposed to uphold context-dependent intermediate cell states benefitting malignancy. LOXL3 (lysyl oxidase-like 3) promotes EMT and has a key role in human melanoma cell survival and maintenance of genomic integrity. To further understand the role of Loxl3 in melanoma, we generated a conditional Loxl3-knockout (KO) melanoma mouse model in the context of BrafV600E-activating mutation and Pten loss. Melanocyte-Loxl3 deletion increased melanoma latency, decreased tumor growth, and reduced lymph node metastatic dissemination. Complementary in vitro and in vivo studies in mouse melanoma cells confirmed Loxl3’s contribution to melanoma progression and metastasis, in part by modulating phenotypic switching through Snail1 and Prrx1 EMT-TFs. Importantly, a novel LOXL3-SNAIL1-PRRX1 axis was identified in human melanoma, plausibly relevant to melanoma cellular plasticity. These data reinforced the value of LOXL3 as a therapeutic target in melanoma. MDPI 2022-02-25 /pmc/articles/PMC8909883/ /pubmed/35267510 http://dx.doi.org/10.3390/cancers14051200 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vázquez-Naharro, Alberto Bustos-Tauler, José Floristán, Alfredo Yuste, Lourdes Oltra, Sara S. Vinyals, Antònia Moreno-Bueno, Gema Fabra, Àngels Portillo, Francisco Cano, Amparo Santamaría, Patricia G. Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival |
title | Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival |
title_full | Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival |
title_fullStr | Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival |
title_full_unstemmed | Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival |
title_short | Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival |
title_sort | loxl3 promotes melanoma progression and dissemination influencing cell plasticity and survival |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909883/ https://www.ncbi.nlm.nih.gov/pubmed/35267510 http://dx.doi.org/10.3390/cancers14051200 |
work_keys_str_mv | AT vazqueznaharroalberto loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT bustostaulerjose loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT floristanalfredo loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT yustelourdes loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT oltrasaras loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT vinyalsantonia loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT morenobuenogema loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT fabraangels loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT portillofrancisco loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT canoamparo loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival AT santamariapatriciag loxl3promotesmelanomaprogressionanddisseminationinfluencingcellplasticityandsurvival |